InvestorsHub Logo
Followers 46
Posts 1658
Boards Moderated 0
Alias Born 09/01/2013

Re: None

Wednesday, 04/20/2016 9:18:31 AM

Wednesday, April 20, 2016 9:18:31 AM

Post# of 977
Stanford is presenting human cd47 data at ASCO from p1

Abstract 3019
A first-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers.

Poster Board: #341
Discussed at the Poster Discussion Session on Sunday, June 5, 2016 4:45 PM - 6:00 PM, at Hall B1
Branimir I. Sikic, MD - Presenter
Stanford University School of Medicine